(Reuters) - LONDON, July 10 - British medical devices maker Corin Group Plc said on Tuesday it was "very hopeful" its new Cormet hip implant would grow to become a market leader in the United States.
Cormet, which is being marketed by U.S. orthopaedics firm Stryker , was approved by the U.S. Food and Drug Administration last week.
Read more at Reuters.com Mergers News
Cormet, which is being marketed by U.S. orthopaedics firm Stryker , was approved by the U.S. Food and Drug Administration last week.
Read more at Reuters.com Mergers News
No comments:
Post a Comment